Aeris AeriSeal System Receives EU Approval for Emphysema Treatment

Aeris, from Woburn, MA, has received CE approval for its Aeriseal system for treating emphysema. The Aeriseal system works by reducing the lung volume in order to improve lung function by improving the ventilation-perfusion mismatch. This is done by delivering a sealing foam to diseased areas of the lung during bronchoscopy. In the weeks after the treatment, air trapped in the sealed part of the lung is gradually absorbed and the area collapses. The space that arises is filled by adjacent lung tissue, allowing it to function more effectively. The procedure is an alternative to the more invasive lung volume reduction surgery which is only used in the most advanced cases of the disease and has a high percentage of complications. Several trials are underway assessing the effectiveness of the new system.
Press release: Aeris Therapeutics Announces CE Mark Approval for the AeriSeal® Emphysematous Lung Sealant System…
Product page: Aeris Aeriseal…
Flashback: Bronchoscopic Biologic Lung Volume Reduction (BLVR) System from Aeris Therapeutics Aims on Emphysema